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Linear peptidomimetics as potent 
antagonists of Staphylococcus 
aureus agr quorum sensing
Georgia Karathanasi1, Martin Saxtorph Bojer1, Mara Baldry1, Bárdur Andréson Johannessen1, 
Sanne Wolff1, Ines Greco  2, Mogens Kilstrup3, Paul Robert Hansen  2 & Hanne Ingmer1
Staphylococcus aureus is an important pathogen causing infections in humans and animals. Increasing 
problems with antimicrobial resistance has prompted the development of alternative treatment 
strategies, including antivirulence approaches targeting virulence regulation such as the agr quorum 
sensing system. agr is naturally induced by cyclic auto-inducing peptides (AIPs) binding to the AgrC 
receptor and cyclic peptide inhibitors have been identified competing with AIP binding to AgrC. 
Here, we disclose that small, linear peptidomimetics can act as specific and potent inhibitors of the 
S. aureus agr system via intercepting AIP-AgrC signal interaction at low micromolar concentrations. 
The corresponding linear peptide did not have this ability. This is the first report of a linear peptide-
like molecule that interferes with agr activation by competitive binding to AgrC. Prospectively, 
these peptidomimetics may be valuable starting scaffolds for the development of new inhibitors of 
staphylococcal quorum sensing and virulence gene expression.
Staphylococcus aureus is a Gram-positive bacterium with pathogenic potential towards humans and animals alike. 
While considered part of the normal human flora with approximately 20–30% of healthy individuals being colo-
nized by S. aureus, it is also capable of opportunistically causing a wide range of infections ranging from mild skin 
infections to severe conditions such as septicaemia. The ability of S. aureus to cause disease is attributed both to 
the acquisition of resistant genes (e.g., giving rise to methicillin resistant Staphylococcus aureus, MRSA) and to the 
production of an impressive collection of virulence factors1–4.
Expression of many of the S. aureus virulence factors is controlled by the accessory gene regulator (agr) quo-
rum sensing system as a response to cell density5. The agr system is composed of two divergent promoters, P2 
and P3. The P2 is responsible for the activation of a four-gene operon which consists of agrB, D, C and A. AgrD 
acts as precursor peptide which is synthesized in the cytoplasm and is then cleaved, modified and transported to 
the extracellular environment by AgrB in the form of a tailed thiolactone ring6. The resulting mature autoinduc-
ing peptide (AIP) consists of 7–9 amino acid residues with a five-residue thiolactone ring which is essential for 
its activity. AgrC and AgrA constitute a classical two component signaling (TCS) module in which AgrC is the 
membrane-bound receptor and AgrA is the cytoplasmic response regulator7. The AIP binds to the AgrC causing 
autophosphorylation of the cytoplasmic domain followed by transfer of the phosphate to AgrA. The phosphoryl-
ation of AgrA leads to conformational changes and subsequently, AgrA can stimulate the expression of RNAIII 
(the effector molecule of agr) via P3. The RNAIII regulation includes various virulence factor genes such as those 
for proteases and toxins8. In particular, RNAIII is responsible for the upregulation of extracellular proteins such 
as α-hemolysin encoded by hla and the downregulation of cell-surface proteins such as Protein-A encoded by 
spa. In this manner, expression of RNAIII changes the adhesion phenotype of S. aureus to an invasive phenotype. 
As the agr system is central to this transition, it has often been proposed as a potential target to deal with S. aureus 
infections.
Inhibition of virulence gene expression is an example of an alternative approach against S. aureus infections 
known as antivirulence therapy. This is an approach that does not affect bacterial viability and it aims to disarm 
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the pathogen which is then expected to be killed by the host immune defense9. Therefore, it is believed that anti-
virulence therapy can pose less selective pressure to bacterial populations compared to antibiotic treatment, thus 
reducing the rate of resistance development to such therapeutic approaches.
Relevant to this approach, antivirulence compounds can potentially interfere with agr components and inhibit 
the expression of S. aureus virulence factors. An example of natural products that can target virulence gene 
expression through AgrC is that of Solonamide A and B which were isolated from a marine Gram-negative bacte-
rium, Photobacterium halotolerans. Importantly, the chemical structures of Solonamides are remarkably similar to 
that of the AIP, indicating that they likely act as competitive inhibitors of AgrC-AIP binding10. Apart from iden-
tifying chemical entities from natural sources that act as agr agonists, many studies to date have also focused on 
the identification and/or synthesis of AIP variants in order to intercept the binding of the naturally produced AIP 
to the AgrC11–15. Protocols for non-standard chemical synthesis of AIPs have been developed16,17 and since agr 
interference may directly impact disease outcome18 and has also been elegantly demonstrated to affect bacterial 
behaviour on surfaces19 it provides attractive new routes of application within S. aureus antivirulence approaches.
Antimicrobial peptides (AMPs) have been detected in almost all living organisms including bacteria, fungi, 
mammals and humans as an integral part of their innate defense system20,21. AMPs target both Gram-positive 
and Gram-negative bacteria and have thus been deemed as potential candidates against bacterial infections and 
alternatives to antibiotics22. Furthermore, AMPs have been shown to display immunomodulatory activities such 
as leukocyte recruitment and suppression of harmful inflammation23. A main characteristic of AMPs is their 
positive charge which facilitates their interaction with the negatively charged bacterial membrane. Moreover, 
they exhibit a combination of hydrophilic and lipophilic properties (amphipathicity) in order to reach and pen-
etrate the bacterial membrane through hydrophobic interactions24. However, one of the main disadvantages is 
their susceptibility to proteases. Therefore, peptide mimetics (peptidomimetics) such as peptoids (N-substituted 
oligomers of Glycine) have been proposed as improved alternatives as they retain the biological activity of the 
parent peptide while simultaneously displaying enhanced stability against proteases25. Peptoids are oligomers of 
N-substituted glycines and differ from α-peptides in that the side chains are attached to the backbone Nα position 
instead of the C-α atom26 (Fig. 1).
To date, studies have focused on the antimicrobial properties of peptoids27–29, including AMPs with peptoid 
residues in selected positions and lysine-peptoid hybrids30–32. These and similar compounds are often referred 
to as peptidomimetics33,34. Due to the need of compounds with novel modes of action such as compounds that 
can inhibit virulence gene expression, peptoids are also an interesting choice for development of new potential 
antivirulence candidates that may modulate the activity spectrum and/or increase the stability of traditional 
peptide-based AIP-AgrC antagonists. A few studies have explored the possibility of using cyclic peptoid mimics 
to intercept AIP-mediated agr activation35,36. To our knowledge, however, no studies have been conducted with 
the specific aim to assess the possibility that linear peptidomimetics could act as agr inhibitors. Here we examine 
the effects of linear peptide-peptoid hybrids on the expression of virulence factors regulated by the agr system 
in Staphylococcus aureus and we focus on the influence of the different side chains on antivirulence properties of 
these novel candidates.
Results
As part of a study examining the antimicrobial activity of eight linear synthetic peptidomimetics identified from 
a combinatorial library, we noticed that some of these compounds could also influence virulence gene expression 
in S. aureus when applied at sub-MIC concentrations. The compounds tested were between 7 and 9 residues 
in length and contained L-lysine, 3-(1-naphthyl)-L-alanine (1-Nal) and the peptoid residues N-butylglycine, 
N-1-naphthylmethylglycine and N-4-methylbenzylglycine. Furthermore, the compounds carried a positive 
charge between 4 and 6 (Supplementary Table S1). Using a simple screen where S. aureus virulence gene expres-
sion is monitored in reporter strains carrying hla, spa or RNAIII promoter fusions (PC322, PC203 and SH101F7, 
respectively)37 we observed that particularly the compounds D1 and D3 and to some extent also C3 repressed hla 
and RNAIII expression while increasing spa expression (Supplementary Fig. S1, Supplementary Table S1). Also, 
when monitored by qPCR, expression of RNAIII was greatly reduced particularly in stationary phase cultures 
of 8325-4 (Fig. 2) that had been exposed to D1 or D3. A third compound, A4, which did not react in the plate 
assay screen and was included as a negative control, showed no effect on RNAIII expression thus also validating 
the plate assay method results. Importantly, the effect on virulence gene expression did not correlate with any 
Figure 1. General structure of peptides and peptoids. The red color indicates one of the side chains highlighting 
the difference between peptides and peptoids.
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antimicrobial effects as assessed from the minimal inhibitory concentrations of the compounds (Supplementary 
Table S2) as seen, for example, when comparing the low or non-modulatory activity of compounds C2, C4 and 
D4 (MICs 64–128 µg/ml) to the activity of D1 and D3 with similar MICs (128 and 64 µg/ml, respectively). These 
results show that linear peptidomimetics can interfere with S. aureus virulence gene expression and the expres-
sion pattern correlates with inhibition of the agr quorum sensing system.
The most active compounds identified in our screen were the D1 and D3 peptide-peptoid hybrids, which 
both have an N-1-naphthylmethylglycine and N-(4-methylbenzyl)glycine residue at the N-terminus that seems 
to be important for activity. A4, that lacked activity, is a peptide containing the non-proteinogenic amino acid 
3-(1-naphthyl)-L-alanine and an L-lysine residue at the N-terminus. Overall, A4 has a positive charge of 6 and 
is more hydrophilic compared to D1 and D3, both of which carry a positive charge of 4. This is also reflected in 
the RP-HPLC retention times where A4 (14.8 min.) elutes earlier compared to the more hydrophobic D1and D3 
(16.9 and 16.1 min. respectively).
To obtain more information about the peptidomimetic properties involved in inhibition of virulence gene 
expression, a glycine scan was performed38 in order to assess the importance of the side-chains for anti-virulence 
activity using D3 as a scaffold (Supplementary Table S1, G1-G7). Compound G3, in which the lysine residue 
in position 3 was substituted with glycine, was highly active against S. aureus virulence gene expresssion. This 
was made evident for G3 by the more pronounced downregulation of hla and RNAIII expression and upreg-
ulation of spa when compared to the other peptidomimetics tested and the parent compound D3 (Fig. 3). The 
derivatives G4 and G7 where lysine was replaced with a glycine residue, appeared to have increased activity 
as opposed to the glycine replacement of the remaining hydrophobic residues N-1-naphthylmethylglycine or 
N-4-methylbenzylglycine, that showed an almost complete loss of activity. Overall, the best combination in this 
series appears to be four hydrophobic groups, one glycine residue and two positively charged lysine residues. The 
balance between charge and hydrophobicity seems to be very important.This is also reflected in the HPLC reten-
tion times, where the most hydrobic compounds are G3(17.5 min.), G4(17.8 min.) and G7(17.5 min.) compared 
to G1, G2, G5 and G6 which have a RT between 14.4 min. and 15.7 min.
The effect of G3 on RNAIII expression was confirmed in a quantitative assay using the reporter strain 
RN10829 WT (a derivative of 8325-4 carrying blaZ gene fused to the P3 RNAIII promoter)39,40. As this reporter 
strain is unable to produce AIPs, induction of agr and β-lactamase activity requires exogenously added AIP for 
instance by supplementation with spent wild type S. aureus supernatant. With the use of this assay we were able to 
confirm that G3 downregulates RNAIII expression (P3 promoter activity) to a much greater extent than the par-
ent D3 compound (Fig. 4). Notably, the MICs of the two compounds are identical (64 µg/ml) and the pronounced 
effect on this alternative agr reporter strain at concentrations well below MIC (i.e., 3 µg/ml) further supports 
that the activity is related to direct agr interference. To evaluate agr inhibition on a wild type S. aureus, we meas-
ured RNAIII levels in the USA300-derivative strain JE2 and observed that treatment with G3 caused a 1000-fold 
reduction in transcript abundance upon entry into stationary phase (Supplementary Fig. S2A). The antivirulence 
activity of G3 was further illustrated by a strong repression of the hemolytic phenotype of S. aureus when grown 
on a blood agar plate in presence of the compound (Supplementary Fig. S2B).
It appeared that subtle modifications to the parent peptidomimetic could have important consequences 
regarding its anti-agr activity. To assess if the inhibitory activity of G3 could be enhanced even further and to 
assess the relevance of the chemical nature of the residue in position three, we synthesized nine new analogues 
where the side-chain in position three of D3 was modified by the introduction of residues with varying proper-
ties; three were cationic or polar (Dap3, S3, T3), three aliphatic (A3, V3, L3) and a further three were aromatic 
(W3, F3 and Nal3) (Supplementary Table S1). Screening of the nine new D3-analogues using the agar diffusion 
reporter assay revealed that the majority of the compounds displayed a level of activity comparable to that of 
G3 with the exception of Dap3, Nal3 and W3 (Fig. 5). When examined in the quantitative β-lactamase assay 
essentially all compounds reduced expression from the P3 promoter as did G3. In contrast, S3 and L3 exhibited 
a moderate reduction in activity, while Dap3 in agreement with the agar diffusion assay showed a complete loss 
of activity. Nal3 and W3 were excluded from further analysis due to adverse effect on the growth of the reporter 
Figure 2. Effect of peptidomimetics on RNAIII expression. The effect of compounds A4, D1, and D3 (all 3 µg/
ml) on RNAIII expression was monitored in S. aureus strain 8325–4 at OD600 0.7 and 1.7. Each data set is based 
on biological duplicates with the level of the untreated culture at OD600 1.7 arbitrarily set to 100(±SD).
www.nature.com/scientificreports/
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strain (Fig. 6). While we were unable to further enhance the activity of G3, relative to this peptidomimetic we 
conclude that is possible (i) to alter the MIC of the peptidomimetic without a concomitant alteration in agr activ-
ity and (ii) to identify a derivative (Dap3) that is completely inactive but displays unaltered MIC. Dap3 differs 
from D3 in the length of aminomethyl side-chain. D3 contains a lysine residue in this position while Dap3 carries 
a positive charge but is three CH2-groups shorter, which makes it more hydrophobic (RT of 18.0 min. vs 16.1 min. 
for D3). For antimicrobial peptides this difference in activity is known as “the snorkel effect” which is proposes 
that the depth which the main-chain sinks into the lipid bilayer is determined by the length of polar residue 
side-chains facing away from it41.
Having shown that peptidomimetics can interfere with virulence gene expression presumably by interfer-
ing with agr, we wanted to further characterize the mode of action. Over a range of sub-MIC concentrations 
(3–12 μg/ml) G3 did not influence growth (Supplementary Fig. S3). Next we wanted to investigate how sensitive 
agr modulation is towards varying concentrations of our peptidomimetics and AIP, as previous studies have 
shown that when a compound acts on agr via AgrC it is most likely agonist concentration dependent40. To address 
this, we monitored the antagonist action of G3 using the P3-blaZ reporter strain assay and observed a direct 
relationship between an increase in G3 concentration and the reduction in P3 promoter activity at a constant AIP 
concentration (Fig. 7A). Moreover, at a constant G3 concentration a gradual increase in AIP concentration led 
to a gradual increase in β-lactamase activity (i.e, lowering the inhibitory effect of the compound) (Fig. 7B). These 
results indicate that G3 (and most likely our other peptidomimetic compounds) interfere with the agr system 
through the AgrC receptor by competing with AIP-I. To further support this notion, we employed a strain with a 
constitutively active AgrC (RN10829 Const.)39 that functions independently of the externally added AIP signal. 
Using such a mutant strain, it is possible to assess whether any interference with the agr system is accomplished 
via or downstream of the AgrC sensor histidine kinase42–45. Corroborating our assumption, the data indicate 
that G3 acts on agr via AgrC as the inhibitory effect on the constitutively active AgrC reporter strain is negligible 
(Fig. 7C).
Figure 3. Effect of compounds G1–G7 on S. aureus virulence gene expression. Peptidomimetics were added 
(10 μg/well) to TSA plates containing SH101F7 (RNAIII::lacZ) (A), PC322 (hla::lacZ) (B) or PC203 (spa::lacZ) 
(C). D3 was included as reference and H2O was used as control.
Figure 4. Effect of D3 and G3 on RNAIII expression in the presence of an active AgrC dependent on externally 
added AIP. Cultures of RN10829 WT were grown to OD600 0.4–0.5 where 10% AIP containing supernatant and 
3 μg/ml compounds (final conc.) were added. DMSO was used both for the positive and the negative controls, 
with and without externally added AIP respectively. Bars represent the mean values (±SD) tested in biological 
triplicates.
www.nature.com/scientificreports/
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The most active peptidomimetics identified thus far (e.g. G3 and A3) are seven residues long and one could 
imagine that they are able to adapt a conformation which mimics AIP-I, thereby exerting their inhibitory/com-
petitive activity. In such a scenario, residue seven might fold back proximal to residue three, thus obtaining a 
conformation as a five-membered pseudo-macrocyclic arrangement alike the AIP (Supplementary Fig. 4). This 
in turn might provide a structural explanation to the finding that G3 and G7, from the glycine scan, grouped 
together in terms of activity. As the macrocyclic structure of S. aureus AIP-I starts with a cysteine and ends with 
the C-terminal methionine, we aimed to test the mimicry hypothesis by synthesis of derivatives of the G3/A3 
backbone with either cysteine, methionine or both appended at the relevant positions. These included Cy3 with 
position three of the G3/A3 backbone substituted with cysteine, A3M7 with a methionine substitution at the 
C-terminus of A3, and Cy3M7 containing both substitutions (Supplementary Table S1). When assayed for their 
agr modulatory activity (Fig. 8), we found that contrary to the hypothesis, neither of the single-substitutions 
led to a reduction in activity and the double-substitution converted the peptidomimetic into a fully inactive 
compound. We tested the possibility that the changes in residues had actually converted the peptidomimetics 
into activators of agr rather than inhibitors. However, we observed no induction of the P3-blaZ reporter by the 
peptidomimetics alone (not shown). Together, this suggests that the mode of action of the active peptidomimetics 
is not easily explained by simple AIP mimicry.
Figure 5. Effect of the nine D3 peptidomimetic analogues on virulence gene expression. Peptidomimetics 
were added (10 μg/well) to TSA plates containing SH101F7 (RNAIII::lacZ) (A), PC322 (hla::lacZ) (B) or PC203 
(spa::lacZ) (C). G3 was included as reference and DMSO was used as control. Virulence gene downregulation is 
represented by a white zone while upregulation by a blue color zone.
Figure 6. Peptidomimetics differentially influence RNAIII expression in the presence of an active AgrC 
dependent on externally added AIP. Cultures of RN10829 WT were grown to OD600 0.4–0.5 where 10% AIP 
containing supernatant and 3 μg/ml peptidomimetics were added. DMSO was used for both the positive and the 
negative controls which were with and without externally added AIP respectively. The data represent the mean 
values (±SD) from 3 individual experiments at 45 minutes after AIP addition.
www.nature.com/scientificreports/
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Finally, an important question regarding the activity of our peptidomimetics was whether their peptoidic 
nature is essential for their antivirulence activity or if peptide analogues could have the same activity. To address 
this, we synthesised the natural peptides PEPD3, PEPG3 and PEPA3 (Supplementary Table S1) corresponding 
to the peptidomimetics D3, G3 and A3, respectively. Strikingly, we observed that while the peptidomimetics 
greatly influence RNAIII, hla and spa expression, their corresponding peptides display essentially a complete 
loss of activity (Fig. 9). Hence, it is clear that the compounds need to be of a peptidomimetic nature to have agr 
modulatory activity.
Discussion
In this study we have found that short linear synthetic peptidomimetics profoundly interfere with virulence gene 
expression in S. aureus. More specifically, these entities inhibit agr mediated quorum sensing and we have demon-
strated that this interference likely occurs via obstructing AgrC activation by its natural AIP agonist.
When assessing the structural components important for activity we found that the G1 peptidomimetic, in 
which N-(1)-napthalenemethylamine of the parent peptidomimetic D3 was replaced with a Gly, had a remarkably 
reduced activity against agr. In contrast, G3, G4 and G7 in which Lys residues were selectively replaced with Gly 
showed a greatly improved agr-inhibitory activity compared to D3. Notably, the degree of interference displayed 
by the different analogues was not the same, suggesting that the position of lysine is important for their antivir-
ulence activity. When the side-chain in position three of G3 was modified we did not further improve activity 
and most derivatives maintained an activity quite similar to that displayed by G3. Interestingly, however, when 
Figure 7. The peptidomimetic G3 acts on agr likely via interception of the AIP-AgrC interaction. Assessment 
of competitive action of G3 in a P3-blaZ reporter strain when applying (A) increasing concentrations of G3 with 
a fixed AIP concentration (10% AIP containing supernatant) and (B) increasing percentages of AIP containing 
supernatant with a fixed G3 concentration (3 μg/ml). The bars represent the mean values (±SD) of technical 
replicates of samples collected 45 minutes after addition of the AIP containing supernatant. The inhibitory effect 
of G3 on a strain expressing a constitutively active AgrC variant (RN10829 Const.) was assessed by treating 
with 3 μg/ml of the analogue (C) using DMSO as a control. The data represent the mean (±SD) of 3 biological 
triplicates of samples obtained 60 minutes after the addition of the peptidomimetic.
www.nature.com/scientificreports/
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substituting with the small, non-proteinogenic amino acid 2,3-diaminopropionic acid (Dap) the peptidomimetic 
was completely inactive. This was despite the addition of the positive charge at this position, which is also a char-
acteristic at this position in the parent compound D3. Overall, the results showed that G3 had the greatest activity, 
Figure 8. Effect of the G3, A3, Cy3, A3M7 and Cy3M7 peptidomimetics on virulence gene expression. 
Peptidomimetics were added (500 μg/ml; 20 μl/well) to TSA plates containing SH101F7 RNAIII::lacZ, PC322 
hla::lacZ and PC203 spa::lacZ. DMSO was used as control. Virulence gene downregulation is represented by a 
white zone while upregulation by a blue color zone.
Figure 9. Effect of D3, G3 and A3 on the virulence gene expression in comparison with their respective 
peptides. Peptidomimetics and their respective peptides were added (500 μg/ml; 20 μl/well) to TSA plates 
containing SH101F7 RNAIII::lacZ (A), PC322 hla::lacZ (B) and PC203 spa::lacZ (C). DMSO was used as 
control. Virulence gene downregulation is represented by a white zone while upregulation by a blue color zone.
www.nature.com/scientificreports/
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suggesting that the positive charge in position three is not important for its antivirulence activity. Importantly, 
the spectrum of anti-agr activity of our peptidomimetics appear to be completely unrelated to any antimicrobial 
activity and we find that the most active entities repress the quorum sensing system of our reporter strains and 
wild type S. aureus strains to a considerable degree at concentrations well below one-tenth of the MIC.
Investigation of the mode of action of G3 showed that this peptidomimetic interferes with the agr system by 
intercepting AIP mediated AgrC receptor activation. This suggests that peptidomimetics can be potential compet-
itors of AIP, the natural ligand of the receptor. Research in this area has mainly focused on structure-activity rela-
tionships (SAR) of AIPs in order to identify compounds that repress the agr system in S. aureus15,46. Specifically, 
studies have shown that the thiolactone macrocycle is important for the inhibitory activity13,18; while linear var-
iants of AIPs do not inhibit (or activate) the agr system18,47. Potent macrocycles interfering with the agr quorum 
sensing system have also been identified from nature. For example, Solonamide B which was isolated from the 
marine bacterium Photobacteriumhalotolerance acts through AgrC and has a chemical structure very similar to 
AIP-I40. Very recently, Vasquez et al. (2017) reported a library of 63 AIP peptidomimetics which were evaluated as 
AgrC receptor modulators. The authors found that three structural properties are important i) the thioester moi-
ety since amide analogs were significantly less active ii) the presence of aromatic Phe residues on the macrocycle 
and iii) a macrocrocyclic ring of seven aliphatic carbon atoms appeared optimal48.
What makes our study interesting is that the chemical structure of our peptidomimetics differs significantly 
from AIPs and Solonamide; being linear and consisting of both amino acid and peptoid residues. We hypothe-
sised that our peptidomimetics could mimic an AIP antagonist by non-covalently folding up like AIP. However, 
our initial efforts to synthesise derivatives with even closer resemblance to AIP-I in the primary structure did not 
support such a scenario as they lost rather than maintained or improved their inhibitory activity.
One of the most interesting findings in this study is that when comparing the anti-virulence activity of our 
best candidates (D3, G3 and A3) with their respective peptides (PEPD3, PEPG3 and PEPA3) the compounds lost 
their ability to repress the agr system. Thus, the loss of anti-virulence activity when peptoid residues are replaced 
by corresponding peptide residues leads to the conclusion that the peptoid structure is essential for agr interfer-
ence. However, at present we cannot exclude an issue with instability of the peptide variants.
Collectively, this study has revealed that peptide-peptoid hybrids can be potent inhibitors of the Staphylococcus 
aureus agr quorum sensing system and that the peptoidic properties are instrumental in this activity. An advan-
tage of our peptidomimetics compared to other compounds with a similar activity is that they are easy to synthe-
size due to their linear structure and thus additional complicated steps to form a macrocyclic ring are not needed. 
Furthermore, peptoid containing compounds are less susceptible to proteolytic degradation making them more 
stable than their peptide counterparts25,49 and studies have shown that peptoid compounds, compared to pep-
tides, can have higher stability, higher tissue accumulation and slower elimination in vivo50. Lastly, the combina-
torial flexibility in synthesis may facilitate future structure-activity relationship studies. Thus, our findings may 
aid future efforts into delineating essential structures needed for agr modulation and has brought forward a novel 
molecular scaffold for development of therapeutic intervention against S. aureus quorum sensing.
Materials and Methods
Synthesis of peptidomimetics. The synthesis of the peptidomimetics was performed as described 
by Oddo et al. (2015)51. According to this, a combination of Fmoc Solid Phase Peptide Synthesis (SPPS) and 
sub-monomer approach was applied. After the synthesis, the peptidomimetics were purified (>95%) by prepara-
tive HPLC and the purity was determined through analytical HPLC. Moreover, the MALDI-TOF-MS was used in 
order to verify the identity of the peptidomimetics51.
Bacterial strains and growth conditions. Strains used in this study and their sources are listed in Table 1. 
Unless otherwise stated, bacteria were grown in Tryptic Soy Broth (TSB) at 37 °C with shaking at 200 rpm, with 
addition of antibiotics when appropriate (5 mg/l erythromycin, 10 mg/l chloramphenicol)
Agar Diffusion Reporter Assay. The reporter assay was conducted as described by Nielsen et al. (2010) 
using three different lacZ transcriptional reporter strains, PC203, PC322 and SH101F37. Test compounds dis-
solved in H2O or DMSO was added to agar wells at indicated concentrations and solvent only was included as a 
control. Incubation until blue color appeared in plates varied from 9 h to 48 h. The ability of the peptidomimetics 
Strain Description Reference
8325–4 S.aureus WT (agr group I) 53
JE2 Plasmid-cured version of CA-MRSA USA300 54
PC203 S. aureus 8325-4 spa::lacZ 55
PC322 S. aureus 8325-4 hla::lacZ 55
RN6911 S. aureus (8325-4 Δagr) 56
RN10829 WT S. aureus WTP2-agrA; P3-blaZ; pagrC-I-WT
39,40
RN10829 Const. S. aureus (Const.)P2- agrA; P3-blaZ; pagrC-I-R238H (pEG11)
39
SH101F7 S. aureus 8325-4 RNAIII::lacZ 57
Table 1. Strains and their sources.
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to influence virulence gene expression was observed based on the color change around the wells; a white halo 
represents downregulation of virulence gene expression, while a blue halo represents upregulation of expression, 
with the size of the halo being indicative of the degree of interference.
Activity of peptidomimetics in WT and Constitutive Active AgrC reporter strains using the 
β-lactamase assay. This assay was used as a quantitative measure of the effect of peptidomimetics on P3 
promoter activity in reporter strains expressing either a wild type AgrC variant (RN10829 WT) or a constitutively 
active AgrC (RN10829 Const.). The method used is described by Nielsen et al. (2014)40. Briefly, 3 μg/ml of the 
peptidomimetics (final concentration) or DMSO (solvent), and 1/10 volume of spent medium containing or free 
from AIP-I were used. The β-lactamase activity of the samples was subsequently determined according to Ji et al. 
(1995) by using the nitrocefin hydrolysis method52.
The WT β-lactamase reporter was further employed in two modified experimental setups. To assess con-
centration dependence, the volume of the added AIP supernatant was kept constant (10% of the total volume) 
and different peptidomimetics concentrations (0.75 μg/ml, 1.5 μg/ml, 3 μg/ml and 6 μg/ml) were tested. To assess 
competition with AIP, peptidomimetics were added to the cell culture at the standard concentration of 3 μg/ml 
together with different percentages of AIP containing supernatant (5%, 15% and 25%). In both assays DMSO was 
used as control.
Reverse Transcriptase-Quantitiative PCR. S. aureus strains (8325-4 or JE2) were grown overnight (24 h, 
37 °C, 200 rpm in TSB) and diluted 100X times in fresh TSB in 100 ml Erlenmeyer flasks. The peptidomimetics 
were added to the flasks at a final concentration of 3 μg/ml and the cultures were incubated at 37 °C with shaking 
at 200 rpm. Samples were collected at OD600 0.7 and 1.7, centrifuged at 4 °C, and the pellets instantly frozen at 
−80 °C.
RNA was purified from the frozen pellets using the Qiagen RNeasy mini-prep kit including a bead-based lysis 
step (FastPrep). DNA was removed with DNase I, RNase-Free (Thermo Scientific) according to the manufactur-
er’s instructions except for an extension of the incubation step to one hour. RNA was reverse transcribed using 
the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems), also including reactions containing 
no reverse transcriptase which were used as negative controls in subsequent amplifications. The cDNA was used 
as a template in the Real-Time PCR using Maxima SYBR Green qPCR Master Mix (Thermo Scientific) on a 
LightCycler® 96 instrument (Roche). RNAIII transcript levels were determined by the comparative cycle thresh-
old method with ileS and pyk used for normalization applying previously published primers11 (Table 2).
Minimum Inhibitory Concentration (MIC). Overnight cultures (24 h, 37 °C, 200 rpm in TSB) of S. aureus 
strains were diluted 5000X in fresh TSB and was aliquoted into 96-well microtiter plates with two-fold dilution 
series of the peptidomimetics ranging from 4 μg/ml to 256 μg/ml (final concentration) to reach an initial cell 
density of approximately 5 × 105 CFU/ml. DMSO was used as control and the plate was incubated for 24 hours at 
37 °C. The MICs of the peptidomimetics were recorded as the lowest concentration for which no bacterial growth 
was observed.
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